Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses
Purpose To summarize the evidence of efficacy and safety of the use of ketamine and
esketamine for depression. Methods A literature search was performed in Medline, the …
esketamine for depression. Methods A literature search was performed in Medline, the …
Comparative effectiveness of intravenous ketamine and intranasal esketamine in clinical practice among patients with treatment-refractory depression: an …
B Singh, S Kung, V Pazdernik, KM Schak… - The Journal of clinical …, 2023 - psychiatrist.com
Objective: Ketamine has been redeveloped as a rapid-acting antidepressant for treatment-
resistant depression (TRD). There is a paucity of literature comparing subanesthetic …
resistant depression (TRD). There is a paucity of literature comparing subanesthetic …
Ketamine and esketamine for depression in daily practice: opportunities and challenges
B Singh - Journal of Clinical Psychopharmacology, 2024 - journals.lww.com
Major depression is a chronic illness where almost 30%–40% of patients do not respond to
conven-tional antidepressants, and for those who do, time to respond is often delayed for …
conven-tional antidepressants, and for those who do, time to respond is often delayed for …
Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: a retrospective study of off-label, at-home use
K Hassan, WM Struthers, A Sankarabhotla… - Frontiers in …, 2022 - frontiersin.org
Intravenous and intranasal ketamine have been shown to be effective therapeutic options in
patients suffering from treatment-resistant depression (TRD). The use of sublingual (SL) …
patients suffering from treatment-resistant depression (TRD). The use of sublingual (SL) …
Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
SY Smith-Apeldoorn, JKE Veraart, HG Ruhé… - BJPsych …, 2022 - cambridge.org
BackgroundIntravenous infusion of ketamine can produce rapid and large symptom
reduction in patients with treatment-resistant depression (TRD) but presents major obstacles …
reduction in patients with treatment-resistant depression (TRD) but presents major obstacles …
Alterations of presynaptic proteins in autism spectrum disorder
The expanded use of hypothesis-free gene analysis methods in autism research has
significantly increased the number of genetic risk factors associated with the pathogenesis of …
significantly increased the number of genetic risk factors associated with the pathogenesis of …
[HTML][HTML] At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world …
Background Improving safe and effective access to ketamine therapy is of high priority given
the growing burden of mental illness. Telehealth-supported administration of sublingual …
the growing burden of mental illness. Telehealth-supported administration of sublingual …
Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis
A Rodolico, P Cutrufelli, A Di Francesco… - Frontiers in …, 2024 - frontiersin.org
Background Unipolar and bipolar depression present treatment challenges, with patients
sometimes showing limited or no response to standard medications. Ketamine and its …
sometimes showing limited or no response to standard medications. Ketamine and its …
Predikce antidepresivního účinku ketaminu na základě klinických parametrů a fenomenologie intoxikace
V Andrashko - 2023 - dspace.cuni.cz
Úvod: ketamin je rychlou možností léčby deprese, avšak dosavadní výzkum neidentifikoval
faktory, umožňující efektivní selekci pacientů s větší pravděpodobností profitu z jeho …
faktory, umožňující efektivní selekci pacientů s větší pravděpodobností profitu z jeho …
Extended release pharmaceutical formulation
PW Glue, NJ Medlicott, PW Surman, Y Long - US Patent 12,090,123, 2024 - Google Patents
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound
OC1C (O) C (OC) OC (CO) C1OC1C (O) C (O) C (OC2C (C (O) C (OC3C (C (O) C (O) C …
OC1C (O) C (OC) OC (CO) C1OC1C (O) C (O) C (OC2C (C (O) C (OC3C (C (O) C (O) C …